Bank of America upgrades Bristol Myers to Buy, lifting its price target to $61 on pipeline catalysts, valuation support, and ...

Futures are trading higher on Monday as we head into the final trading weeks of 2025. All of the major indices were hit hard ...

If you are wondering whether Bristol-Myers Squibb is quietly becoming a value opportunity or just a classic value trap, you ...

What Happened? Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) jumped 2.6% in the afternoon session after ...

Neutral sector-focused overview describing factual commentary surrounding Bristol Myers Squibb within the wider ...

Bristol Myers’ stock rallied Wednesday as investors maintained high hopes for Cobenfy as an Alzheimer’s treatment, even ...

Bristol Myers Squibb Bristol Myers Squibb (NYSE: BMY) recently reported its Q1 results, with revenues and earnings above the street estimates. The company reported revenue of $11.9 billion and an ...

BioNTech and Bristol Myers Squibb share positive data from Phase 2 trial of pumitamig plus chemotherapy for triple-negative ...

Bristol Myers Squibb raised its quarterly dividend by 1.6% to 63 cents a share from 62 cents a share. The new payout, equal to $2.52 per share a year, represents a 4.9% annual yield, based on the ...

By Jonathan Stempel NEW YORK, Dec 1 (Reuters) - A U.S. judge on Monday rejected Bristol Myers Squibb's bid to dismiss a $6.7 ...

Global interim Phase 2 data in locally advanced/metastatic triple-negative breast cancer (”TNBC”) show encouraging antitumor activity for ...

This initiative marks among the BMS Foundation’s first grants in India to increase access to screening and build capacity to ...